Research That Makes a Difference
It’s our goal to support scientists and researchers who will produce results that will help combat the impact of HIV, HBV, HCV and HTLV-1 locally in Australia and in the Southeast Asia and Pacific regions.
What We Do
Our Research
Areas of Research
The Australian Centre for HIV and Hepatitis Virology Research (ACH4) supports virological and immunological research outcomes that directly address these four infectious diseases.
ACH4 financially supports scientists to translate biomedical discoveries to health care and biotechnology outcomes.
Research projects that focus on developing vaccine candidates, antiviral drug targets, and novel diagnostics and prognostics for HIV, HBV, HCV, and HTLV-1 molecular tools for tracking epidemics caused by these organisms, new tests for supporting vaccine and antiviral trials are all supported.
Research projects based on clinical data and specimens from patients with HIV or HCV stored by the Immunovirology Research Network (IVRN) are encouraged. These projects include samples from the STEAL study (evaluating antiretroviral therapy in patients with HIV) and the ATAHC study (evaluating the natural history and efficacy of antiviral treatment in primary Hepatitis C infection), as well as HIV/HBV and HIV/HCV co-infection cohorts.
Funding for such research is intended to complement and translate basic research in the virology and immunology of HIV, HBV, HCV and HTLV-1 that are already funded by other granting bodies.
Diagnostics and Prognostics
Antiviral Targets
Vaccines and Immunotherapy
How Can I...
Focus Your Efforts
ACH4 oversees three major activities in its effort to deliver these virological and immunological research findings. Learn more about these activities and where you can take an active role.
Learn more
Our Research
Join
us in the search for improved treatments
& ultimate cures.
ACH4 supports the objectives and indicators of the National Blood Borne Viruses and Sexually Transmissible Infectious Diseases Research Strategy by encouraging translational research in HIV, Hepatitis B and C and HTLV-1, including the impact these diseases make on the indigenous community.
